Core Viewpoint - Rosen Law Firm is reminding investors who purchased Inovio Pharmaceuticals, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on April 7, 2026 [1]. Group 1: Class Action Details - Investors who purchased Inovio securities between October 10, 2023, and December 26, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by April 7, 2026 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Case Allegations - The lawsuit alleges that during the Class Period, defendants made false and misleading statements regarding Inovio's CELLECTRA device manufacturing deficiencies [5]. - It is claimed that Inovio was unlikely to submit the INO-3107 Biologics License Application to the FDA by the second half of 2024 due to insufficient information [5]. - The lawsuit asserts that the overall regulatory and commercial prospects of INO-3107 were overstated, leading to material misstatements by the defendants [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has recovered hundreds of millions of dollars for investors [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has received recognition for its attorneys [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ramaco Resources, Inc. securities between July 31, 2025, and October 23, 2025, of the March 31, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Ramaco securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court by March 31, 2026, to serve as lead plaintiff [2] - The lead plaintiff acts on behalf of other class members in directing the litigation [2] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company and has been ranked highly for its number of settlements since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3] Group 3: Case Allegations - The lawsuit alleges that Ramaco's defendants made materially false and misleading statements regarding mining activities at the Brook Mine, overstating development progress [4] - It is claimed that no significant mining activity had commenced, and as a result, positive statements about Ramaco's business were misleading [4] - Investors reportedly suffered damages when the true details about the company's operations were revealed [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Kyndryl Holdings, Inc. securities between August 7, 2024, and February 9, 2026, of the April 13, 2026, deadline to become a lead plaintiff in a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Kyndryl securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by April 13, 2026 [3]. - The lawsuit alleges that Kyndryl's financial statements were materially misstated, lacked adequate internal controls, and that the company would be unable to timely file its Quarterly Report for the quarter ended December 31, 2025 [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time and being ranked No. 1 for securities class action settlements in 2017 [4]. - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]. - Founding partner Laurence Rosen was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020, and many attorneys at the firm have received accolades from Lawdragon and Super Lawyers [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Trip.com Group Limited due to allegations of materially misleading business information [1] Group 1: Investigation and Legal Action - Investors who purchased Trip.com Group securities may be entitled to compensation through a class action lawsuit without any out-of-pocket fees [2] - The Rosen Law Firm is preparing a class action to seek recovery of investor losses related to Trip.com [2] Group 2: Stock Performance and Regulatory Issues - Trip.com stock fell 17% on January 14, 2026, after the company disclosed it is under investigation by China's market regulator for potential antitrust violations [3] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [4] - The firm has been ranked highly for its number of securities class action settlements and has recovered hundreds of millions of dollars for investors [4]

Core Viewpoint - Rosen Law Firm is reminding former stockholders of Smartsheet Inc. about a class action lawsuit related to the company's January 2025 sale to a consortium led by Blackstone, Vista Equity Partners, and Platinum Falcon, with a lead plaintiff deadline of February 24, 2026 [1] Group 1: Class Action Details - Former Smartsheet stockholders may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 24, 2026 [1] - The complaint alleges that Smartsheet's solicitation of stockholder approval for the Buyout involved a false and misleading Proxy statement that mischaracterized the company's financial performance [1] Group 2: Allegations Against Defendants - The defendants are accused of intentionally portraying Smartsheet's quarterly earnings negatively and emphasizing a fabricated financial metric to solicit approval for the Buyout [1] - Mark P. Mader, a defendant, is alleged to have failed in his disclosure duties by not exercising reasonable care [1] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company and being ranked highly for settlements since 2013 [1] - In 2019, the firm secured over $438 million for investors, showcasing its capability in handling such cases [1]

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Class A common stock of NuScale Power Corporation, alleging misleading statements and undisclosed risks related to the company's commercialization strategy during the specified Class Period [1][5]. Group 1: Lawsuit Details - The class action lawsuit is on behalf of purchasers of NuScale Class A common stock between May 13, 2025, and November 6, 2025 [1]. - The lawsuit claims that NuScale made false and misleading statements regarding ENTRA1 Energy LLC's experience and capabilities in nuclear power generation, which were critical to NuScale's commercialization strategy [5]. - The lawsuit alleges that ENTRA1 had never built or operated significant projects in the nuclear power field, exposing NuScale to undisclosed risks of failure and regulatory challenges [5]. Group 2: Participation Information - Investors who purchased NuScale Class A common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, investors can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must move the Court by April 20, 2026, to represent other class members in the litigation [1][3]. Group 3: Rosen Law Firm Background - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been recognized for its success in securities class action settlements, ranking No. 1 in 2017 and consistently in the top 4 since 2013, recovering hundreds of millions for investors [4].

Core Viewpoint - Rosen Law Firm is reminding sellers of Masonite International Corporation common stock of a class action lawsuit with a lead plaintiff deadline of April 7, 2026, for those who sold shares between June 5, 2023, and February 8, 2024 [1] Group 1: Class Action Details - A class action lawsuit has been filed against Masonite for material omissions and misrepresentations regarding Owens Corning's offers to purchase Masonite's stock at significant premiums, which were not disclosed to investors [4] - Investors who sold Masonite common stock during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in recovering hundreds of millions for investors [3] - The firm has been recognized for its leadership in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [3] Group 3: Next Steps for Investors - Interested investors can join the Masonite class action by visiting the provided link or contacting the firm directly for more information [2][5] - It is noted that no class has been certified yet, and investors may choose to remain absent or select their own counsel [6]

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of REGENXBIO, Inc. (NASDAQ: RGNX) between February 9, 2022 and January 27, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 14, 2026. SO WHAT: If you purchased REGENXBIO securities during the Class Period you may be enti ...

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CoreWeave, Inc. (NASDAQ: CRWV) between March 28, 2025 and December 15, 2025, both dates inclusive (the “Class Period”), of the important March 13, 2026 lead plaintiff deadline. SO WHAT: If you purchased CoreWeave securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. W ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased PomDoctor Ltd. securities during the specified Class Period of the upcoming lead plaintiff deadline for a class action lawsuit [1] Group 1: Class Action Details - The class action lawsuit has been filed against PomDoctor Ltd. for misleading statements and fraudulent activities during the Class Period from October 9, 2025, to December 11, 2025 [4] - Investors who purchased PomDoctor securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1][4] - The deadline to move the Court to serve as lead plaintiff is April 7, 2026, and a lead plaintiff acts on behalf of other class members [2] Group 2: Allegations Against PomDoctor - The lawsuit alleges that PomDoctor was involved in a fraudulent stock promotion scheme that included misinformation on social media and impersonation of financial professionals [4] - It is claimed that insiders used offshore accounts to facilitate the coordinated dumping of shares during a price inflation campaign [4] - The public statements made by PomDoctor omitted critical information regarding false rumors and artificial trading activity that influenced the stock price [4] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering significant amounts for clients [3]